Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TDS Medlink is a specialized pharmaceutical company focused on the design, development, and manufacturing of Transdermal Drug Delivery Systems (TDS). The company provides a range of transdermal patches for diverse therapeutic applications, including chronic pain management, smoking cessation, and cardiovascular health. Utilizing advanced formulation technologies, TDS Medlink ensures precise drug release profiles and improved patient compliance compared to traditional oral or injectable routes. The firm operates a GMP-compliant manufacturing facility in India and collaborates with international partners for the commercialization of transdermal products. Their portfolio includes well-established treatments such as nicotine, fentanyl, and nitroglycerin patches.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TDS Medlink.